Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review
about
Cutaneous manifestations of hepatitis C in the era of new antiviral agentsTreatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug TherapyViral hepatitis screening guideline before biological drug use in rheumatic patientsManagement of psoriasis patients with hepatitis B or hepatitis C virus infection2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis CEtanercept: a review of its use in autoimmune inflammatory diseases.Side-effects of anti-inflammatory therapy in uveitis.Safety considerations when using anti-TNFα therapy to treat Crohn's disease.Infection risk associated with anti-TNF-α agents: a review.Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.Biological therapy in arthritis patients with hepatitis B or C infection: a multicenter retrospective case series.Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases.Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.Assessment and monitoring of biologic drug adverse events in patients with psoriasis.2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
P2860
Q26773669-6F28C517-8924-4B7D-9AAE-0195A6F7FC99Q28073100-9161BE2C-22C9-4157-BBF2-4B5A1CD96C17Q28076767-2AFC80B1-6821-4785-860C-5C4D5DEC56FAQ28078157-653D1290-09D1-43E6-9068-97AF3B70DE73Q34500921-677B67F2-8A48-4699-B30A-453DA6BED396Q35659760-0981D295-E9FD-4EB4-92C8-8989FC90F22AQ36009894-6061C8A6-2A71-4628-A438-E67546609AD5Q36522235-99A2BD9C-E709-43AF-994C-F76AA570B081Q38230740-641E5749-48A5-4EA2-8139-78E23729F2B4Q38261127-73D38723-2445-4F94-BB88-533CE0106A2CQ38268598-6EF702FB-3B0A-4872-A701-B91F3A052E9BQ38335718-70EA0A40-859B-4C76-A91F-64A33C30C87AQ38539281-995A3A1B-2A64-4B69-BA9A-21D0CE91B175Q38669228-DDD754EF-B6BB-4B71-8B3A-2B6914CC4232Q38986603-C04B3E82-B384-4226-9A14-66C0A41EC917Q47098502-5BCDF70F-B5AE-46EC-8A19-30EE71CD65D2Q47102520-06FBE7B9-5FF2-47C4-899C-6F813CFB4845Q47112883-FBD28F6F-EFC9-4EB1-B4BA-C7D473DF6AC3Q47546977-B931BA8E-DAA4-42DA-980A-4009F7EA1043Q48163642-4C0A001E-A51D-40FC-9667-BA7692FE83E6Q55153984-9DF6A0C1-9592-4A06-BF1A-25AE19520B8BQ57245378-85E8329F-932B-4263-87E3-1A981038B4A0
P2860
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@ast
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@en
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@nl
type
label
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@ast
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@en
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@nl
prefLabel
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@ast
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@en
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@nl
P2860
P50
P3181
P356
P1476
Tumor necrosis factor-α inhibi ...... omprehensive literature review
@en
P2860
P304
P3181
P356
10.3748/WJG.V19.I44.7867
P407
P577
2013-11-28T00:00:00Z